Corient Private Wealth
HUMA icon

Corient Private Wealth’s Humacyte HUMA Stock Holding History

Corient Private Wealth’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9K Buy
+26,748
New +$24.8K ﹤0.01% 3021
2024
Q4 		– Sell
-10,000
Closed -$54.4K – 2426
2024
Q3 		$54.4K Buy
+10,000
New +$65.9K ﹤0.01% 2386

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Corient Private Wealth's HUMA Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Humacyte (HUMA) in Q2 2026: 26,748 shares worth $20.9K. The stake represents ﹤0.01% of the portfolio and ranks #3021 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in HUMA as recently as Q3 2024.

Corient Private Wealth first reported a position in HUMA in Q3 2024 and has held it in 2 quarters since. The position peaked at $54.4K in Q3 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Corient Private Wealth held 26,748 shares of Humacyte worth $20.9K as of Q2 2026.
  • Humacyte was a new Corient Private Wealth position in Q2 2026.
  • Humacyte made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #3021 holding.
  • Corient Private Wealth first reported a position in Humacyte in Q3 2024 and has held it in 2 quarters since.
  • Corient Private Wealth's Humacyte position peaked at $54.4K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.